Determine biomarkers for Alzheimer's and other neurodegenerative diseases using comprehensive analysis of multi-omics data including genomics, epigenomics, metabolomics, proteomics, etc.
Large cohorts with phenotype data on dementia are available through the following resources (incomplete table of data types):
Dr. Sudha Seshadri, the Founding Director of The Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, Dr. Claudia Satizabal, Dr. Radek Dobrowolski, Dr. Qitao Ran, and Dr. Miranda Orr from Wake Forest University.
multiomics_analysis_for_dementia.txt · Last modified: 2024/07/24 19:53 by admin